Drummand M, Members of the ISPOR HTA Council Working Group on HTA in Pluralistic Healthcare Systems, Ronquest N. A case of multitasking: conducting and using HTA and HEOR in pluralistic healthcare systems. Value & outcomes spotlight. 2022 Jul;8(4):7-9.
Brazelton A, Yande S, Pope R, Johnson ML, Musher B, Trivedi MV. Racial and ethnic differences in capecitabine toxicity in patients with gastrointestinal tract cancers. Ann Gastroenterol. 2022 Mar;35(2):182-6. doi: 10.20524/aog.2022.0688.
Dubner SJ, Teutsch C, Huisman MV, Diener H-C, Halperin J, Rothman KJ, Ma C-S, Chuquiure-Valenzuela E, Bergler-Klein J, Zint K, Franca LR, Lu S, Paquette M, Lip GYH. Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF. ESC Heart Fail. 2020 Oct;7(5):2679-89. doi: 10.1002/ehf2.12857
Wolowacz SE. Task force recommendations on the collection of health-state utility data in clinical studies: an interview with Sorrel E. Wolowacz, PhD, Co-Chair, on good practices for Outcomes Research Task Force. Value & outcomes spotlight. 2016 Sep;2(5):22-3.
Williams RE, Bosnic N, Sweeney CT, Duncan AW, Levine KB, Brogan M, Cook SF. Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec. Pain Res Manag. 2008;13(5):395-400.